Is a low Anti-TG antibody result normal?

Yes, a low Anti-TG antibody result is completely normal and actually the desired outcome. Low or undetectable levels (typically under 4 IU/mL) indicate your immune system isn't attacking your thyroid gland, suggesting healthy thyroid function.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Anti-TG Antibodies and Their Role

Anti-thyroglobulin antibodies (Anti-TG or TgAb) are autoantibodies that your immune system produces when it mistakenly identifies thyroglobulin—a protein naturally produced by your thyroid gland—as a foreign threat. These antibodies are one of several markers doctors use to evaluate thyroid health and diagnose autoimmune thyroid conditions.

When you receive your lab results showing low Anti-TG antibody levels, this is actually good news. It means your immune system is functioning properly and not attacking your thyroid tissue. Understanding what these antibodies represent and why low levels are beneficial can help you better interpret your thyroid test results and overall health status.

What Are Normal Anti-TG Antibody Levels?

Normal Anti-TG antibody levels vary slightly between laboratories due to different testing methods, but generally fall within these ranges:

Anti-TG Antibody Level Interpretation

Anti-TG LevelInterpretationClinical SignificanceFollow-up Needed
Undetectable<1 IU/mLNormal/NegativeNo autoimmune activityNo, unless symptoms
Low1-4 IU/mLNormalHealthy thyroid functionNo, unless symptoms
Borderline4-20 IU/mLSlightly elevatedMay indicate early autoimmune activityConsider retesting in 6-12 months
High>20 IU/mLPositive/ElevatedSuggests autoimmune thyroid diseaseYes, comprehensive thyroid evaluation

Reference ranges may vary by laboratory. Always interpret results with your healthcare provider.

  • Less than 4 IU/mL (most common reference range)
  • Less than 20 IU/mL (some laboratories)
  • Undetectable or negative (optimal result)

A low result means your levels fall below these thresholds, which is the expected finding in healthy individuals. In fact, approximately 90% of people without thyroid disease have undetectable or very low Anti-TG antibody levels. This indicates that your immune system is not producing antibodies against your thyroid tissue.

Why Low Levels Are Considered Healthy

Low Anti-TG antibody levels suggest that your thyroid gland is functioning without autoimmune interference. When these antibodies are absent or minimal, it indicates that your immune system recognizes thyroglobulin as a normal body protein rather than attacking it. This is crucial for maintaining proper thyroid hormone production and overall metabolic health.

When Are Anti-TG Antibodies Tested?

Healthcare providers typically order Anti-TG antibody tests in specific clinical situations. Understanding when and why this test is performed can help you appreciate the significance of your results.

Common Reasons for Testing

  • Suspected autoimmune thyroid disease (Hashimoto's thyroiditis or Graves' disease)
  • Unexplained thyroid enlargement (goiter)
  • Family history of thyroid disorders
  • Symptoms of thyroid dysfunction despite normal TSH levels
  • Monitoring after thyroid cancer treatment
  • Evaluation of thyroid nodules

Anti-TG antibodies are often tested alongside other thyroid markers, including TSH, Free T4, Free T3, and anti-thyroid peroxidase antibodies (TPOAb). This comprehensive panel provides a complete picture of thyroid function and helps identify autoimmune involvement. Regular monitoring of your thyroid health through comprehensive testing can help catch potential issues early.

The Connection Between Anti-TG and Thyroid Conditions

While low Anti-TG antibody levels are normal and healthy, elevated levels can indicate various thyroid conditions. Understanding this connection helps contextualize why low levels are reassuring.

Conditions Associated with Elevated Anti-TG

High Anti-TG antibody levels are most commonly associated with:

  • Hashimoto's thyroiditis (found in 60-80% of cases)
  • Graves' disease (found in 20-40% of cases)
  • Postpartum thyroiditis
  • Subacute thyroiditis
  • Thyroid cancer (particularly after treatment)

The absence of these antibodies (low levels) suggests that autoimmune processes are not affecting your thyroid gland. However, it's important to note that some people with thyroid conditions may still have normal Anti-TG levels, which is why comprehensive testing including multiple markers provides the most accurate assessment.

Factors That Can Influence Anti-TG Levels

Several factors can affect Anti-TG antibody measurements, though low levels generally remain stable in healthy individuals:

Biological Factors

  • Age (antibody prevalence slightly increases with age)
  • Gender (more common in women)
  • Pregnancy (can temporarily affect antibody levels)
  • Iodine intake (deficiency or excess can influence thyroid function)
  • Genetic predisposition to autoimmune conditions

Environmental and Lifestyle Factors

  • Stress levels (chronic stress can affect immune function)
  • Viral infections (can trigger autoimmune responses)
  • Certain medications (interferon, lithium)
  • Radiation exposure
  • Dietary factors (selenium and vitamin D status)

Despite these potential influences, maintaining low Anti-TG antibody levels is typically a sign of good thyroid health and proper immune system regulation.

Interpreting Your Results in Context

A low Anti-TG antibody result should always be interpreted alongside other thyroid function tests and clinical symptoms. Here's how to understand your results comprehensively:

Complete Thyroid Panel Interpretation

Your Anti-TG results are most meaningful when considered with:

  • TSH (Thyroid Stimulating Hormone): Primary screening test for thyroid function
  • Free T4: Active thyroid hormone levels
  • Free T3: Additional active hormone assessment
  • TPOAb (Anti-TPO antibodies): Another autoimmune marker often more sensitive than Anti-TG

If all these markers are within normal ranges, including low Anti-TG antibodies, it strongly suggests healthy thyroid function without autoimmune involvement. Regular monitoring through comprehensive testing can help you maintain optimal thyroid health.

When to Retest Anti-TG Antibodies

For individuals with low Anti-TG antibody levels and no thyroid symptoms, routine retesting is typically not necessary. However, certain situations may warrant follow-up testing:

  • Development of thyroid-related symptoms (fatigue, weight changes, temperature sensitivity)
  • Family history of autoimmune thyroid disease
  • Other autoimmune conditions diagnosed
  • Pregnancy planning or postpartum period
  • Significant changes in iodine intake or exposure

Your healthcare provider can determine the appropriate testing frequency based on your individual risk factors and clinical presentation.

Maintaining Healthy Thyroid Function

While low Anti-TG antibody levels indicate good thyroid health, there are proactive steps you can take to maintain optimal thyroid function:

Nutritional Support

  • Ensure adequate iodine intake (150 mcg daily for adults)
  • Include selenium-rich foods (Brazil nuts, seafood, eggs)
  • Maintain sufficient vitamin D levels
  • Consume zinc-rich foods (oysters, beef, pumpkin seeds)
  • Limit excessive soy consumption if you have thyroid concerns

Lifestyle Factors

  • Manage stress through relaxation techniques
  • Maintain regular sleep patterns
  • Exercise regularly but avoid overtraining
  • Limit exposure to environmental toxins
  • Avoid smoking and excessive alcohol consumption

The Bottom Line on Low Anti-TG Results

A low Anti-TG antibody result is not only normal but also desirable. It indicates that your immune system is not attacking your thyroid gland, which is essential for maintaining healthy thyroid function and overall metabolic health. These low levels suggest that you don't have an autoimmune thyroid condition like Hashimoto's thyroiditis or Graves' disease.

Remember that thyroid health is best assessed through comprehensive testing that includes multiple markers. While low Anti-TG antibodies are reassuring, they represent just one piece of the thyroid health puzzle. Regular monitoring, especially if you have risk factors or symptoms, can help ensure early detection of any thyroid issues that may develop over time.

If you have concerns about your thyroid function despite normal Anti-TG levels, discuss comprehensive thyroid testing with your healthcare provider. They can help determine whether additional testing or monitoring is appropriate based on your individual health profile and symptoms.

References

  1. Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyroglobulin assays. Clinical Chemistry. 1996;42(1):164-173.[PubMed]
  2. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology & Metabolism. 2002;87(2):489-499.[PubMed][DOI]
  3. McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42(2):252-265.[PubMed][DOI]
  4. Sinclair D. Clinical and laboratory aspects of thyroid autoantibodies. Annals of Clinical Biochemistry. 2006;43(3):173-183.[PubMed][DOI]
  5. Mariotti S, Caturegli P, Piccolo P, Barbesino G, Pinchera A. Antithyroid peroxidase autoantibodies in thyroid diseases. Journal of Clinical Endocrinology & Metabolism. 1990;71(3):661-669.[PubMed][DOI]
  6. Vanderpump MP. The epidemiology of thyroid disease. British Medical Bulletin. 2011;99:39-51.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my Anti-TG antibodies at home?

While Anti-TG antibodies aren't included in SiPhox Health's base programs, you can test your thyroid health comprehensively with the Core Health Program by adding the Thyroid+ expansion, which includes TPOAb (another important thyroid antibody), Free T3, and Free T4 testing along with TSH from the base panel.

What is the normal range for Anti-TG antibodies?

Normal Anti-TG antibody levels are typically less than 4 IU/mL, though some laboratories use less than 20 IU/mL as their reference range. Undetectable or negative results are considered optimal and indicate no autoimmune activity against the thyroid.

Can Anti-TG levels change over time?

Yes, Anti-TG levels can change, though in healthy individuals they typically remain low. Factors like developing an autoimmune condition, pregnancy, viral infections, or significant stress can potentially trigger antibody production. However, if your levels are currently low and you have no symptoms, they're likely to remain stable.

Should I be concerned if my Anti-TG is low but I have thyroid symptoms?

Low Anti-TG antibodies don't rule out all thyroid conditions. Some people with thyroid dysfunction have normal antibody levels. If you're experiencing symptoms like fatigue, weight changes, or temperature sensitivity, discuss comprehensive thyroid testing with your healthcare provider, including TSH, Free T4, Free T3, and TPOAb.

What's the difference between Anti-TG and TPOAb antibodies?

Both are thyroid autoantibodies, but they target different proteins. Anti-TG antibodies attack thyroglobulin, while TPOAb antibodies target thyroid peroxidase. TPOAb is often more sensitive for detecting autoimmune thyroid disease, particularly Hashimoto's thyroiditis. Many doctors test both for a complete autoimmune assessment.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details